Novel use of peptide compounds for treating central neuropathic pain

Details for Australian Patent Application No. 2004294714 (hide)

Owner Schwarz Pharma AG

Inventors Stohr, Thomas

Agent Davies Collison Cave

Pub. Number AU-B-2004294714

PCT Pub. Number WO2005/053667

Priority 03029 632.1 22.12.03 EP; 03027 742.0 02.12.03 EP; 60/530,895 22.12.03 US

Filing date 2 December 2004

Wipo publication date 16 June 2005

Acceptance publication date 10 December 2009

International Classifications

A61K 31/165 (2006.01) - having aromatic rings, e.g. colchicine, atenolol, progabide

A61K 38/03 (2006.01) Medicinal preparations containing peptides - Peptides having up to 20 amino acids in an undefined or only partially defined sequence

Event Publications

8 June 2006 PCT application entered the National Phase

  PCT publication WO2005/053667 Priority application(s): WO2005/053667

10 December 2009 Application Accepted

  Published as AU-B-2004294714

8 April 2010 Standard Patent Sealed

16 December 2010 Alteration of Name

  The name of the patentee has been altered to UCB Pharma GmbH

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004294724-Drug delivery vehicles and uses thereof

2004294713-Pharmaceutical uses of bisphosphonates